OrisDX provides a saliva-based molecular detection method to check oral cavity pre-malignancies and cancers.
OrisDX provides a saliva-based molecular detection method to check oral cavity pre-malignancies and cancers.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 5, 2022 | Grant | $200K | 1 |
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Grant |